PROCEPT BioRobotics Corp Files 8-K on Director Changes
Ticker: PRCT · Form: 8-K · Filed: Jul 19, 2024 · CIK: 1588978
Sentiment: neutral
Topics: corporate-governance, officer-compensation, filing-update
Related Tickers: PRCT
TL;DR
PROCEPT BioRobotics Corp 8-K: Director shuffle and comp details filed.
AI Summary
PROCEPT BioRobotics Corporation filed an 8-K on July 18, 2024, reporting on the departure of a director, election of a new director, and compensatory arrangements. The filing also includes financial statements and exhibits.
Why It Matters
This filing provides updates on the company's board of directors and executive compensation, which can be important for investors to understand governance and potential future financial impacts.
Risk Assessment
Risk Level: low — The filing is routine and reports on corporate governance changes and financial statements, not indicating immediate operational or financial distress.
Key Players & Entities
- PROCEPT BioRobotics Corporation (company) — Registrant
- July 18, 2024 (date) — Date of earliest event reported
- 150 Baytech Drive San Jose, California 95134 (address) — Principal executive offices
- 650-232-7200 (phone_number) — Registrant's telephone number
FAQ
Who departed from the board of directors?
The filing indicates the departure of a director, but the specific name is not detailed in the provided text.
Who was elected as a new director?
The filing states the election of a new director, but the specific name is not provided in the excerpt.
What other items are covered in this 8-K filing?
Besides director changes, the filing covers compensatory arrangements of certain officers and includes financial statements and exhibits.
What is the principal executive office address for PROCEPT BioRobotics Corporation?
The principal executive offices are located at 150 Baytech Drive, San Jose, California 95134.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated July 18, 2024.
Filing Stats: 959 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2024-07-19 17:24:27
Key Financial Figures
- $0.00001 — ge on which registered Common Stock, $0.00001 par value per share PRCT The Nasdaq Glo
Filing Documents
- prct-20240718.htm (8-K) — 32KB
- 0001628280-24-032343.txt ( ) — 154KB
- prct-20240718.xsd (EX-101.SCH) — 2KB
- prct-20240718_lab.xml (EX-101.LAB) — 21KB
- prct-20240718_pre.xml (EX-101.PRE) — 12KB
- prct-20240718_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROCEPT BIOROBOTICS CORPORATION July 19, 2024 By: /s/ Alaleh Nouri Alaleh Nouri Chief Legal Officer and Secretary